Docetaxel

Land: Nya Zeeland

Språk: engelska

Källa: Medsafe (Medicines Safety Authority)

Aktiva substanser:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

Tillgänglig från:

REX Medical Ltd

INN (International namn):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

Dos:

20 mg/mL

Läkemedelsform:

Concentrate for infusion

Sammansättning:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Enheter i paketet:

Vial, glass, Diluent, 1.5 mL

Klass:

Prescription

Receptbelagda typ:

Prescription

Tillverkad av:

Cipla Ltd

Terapeutiska indikationer:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Produktsammanfattning:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Tillstånd datum:

2006-06-23